98%
921
2 minutes
20
Systemic lupus erythematosus patients' brain functional network impairments are incompletely clarified. This study investigates the brain functional network topological alterations in systemic lupus erythematosus and the application of machine learning to the classification of systemic lupus erythematosus and healthy controls. Resting-state functional MRI data from 127 systemic lupus erythematosus patients and 102 healthy controls were used. The pre-processing process involved using automated anatomical labelling atlas to compute time series data for 116 brain regions. A functional connectivity network was then created by assessing the Pearson correlation between the time series of these brain regions. The GRETNA toolbox was used to compute the difference in topological attributes between groups. Variations in regional networks among groups were evaluated using non-parametric permutation tests that rely on network-based statistical analysis. With the functional connectivity network metrics as features and network-based statistical analysis as the feature selection method, network-based statistical analysis Predict software was used to classify systemic lupus erythematosus from controls by support vector machine. The subnets that contributed the most to systemic lupus erythematosus classification were also identified. For global indicators, the systemic lupus erythematosus group exhibited significantly lower values for the normalized clustering coefficient ( = 0. 0317) and small-world index ( = 0.0364) compared to the healthy controls group. After false discovery rate correction, the differences in Betweeness Centrality, Degree Centrality, Node Efficiency, Node Local Efficiency and other local indexes between the two groups were not retained. No correlation was found between clinical data and network indicators. Systemic lupus erythematosus group had a significantly reduced connection with a 12-node, 11-edge subnetwork ( = 0.024). In conclusion, systemic lupus erythematosus patients exhibit suboptimal global brain functional connectivity network topology and the presence of a subnetwork with abnormally reduced connectivity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11979335 | PMC |
http://dx.doi.org/10.1093/braincomms/fcaf130 | DOI Listing |
J Pharmacol Exp Ther
July 2025
Department of Pharmacy Practice, Parul Institute of Pharmacy & Research, Parul University, Limda, Waghodia, Vadodara, Gujarat, India. Electronic address:
Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by widespread inflammation and immune system dysregulation. Recent research suggests that the gut microbiota may play a role in the development of SLE by modulating immune system responses, affecting cytokine production, and altering the activity of T and B cells lymphocytes. As a result, there is a growing interest in microbiota-targeted therapies, including probiotics, dietary changes, and fecal microbiota transplantation.
View Article and Find Full Text PDFRheumatology (Oxford)
September 2025
Department of Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Objectives: Many patients with systemic sclerosis (SSc) experience impaired hand function, yet the precise nature and impact of this impairment remains unclear. In this study, we explored the determinants of hand function impairment in SSc from a patient perspective and its impact on daily life. Additionally, we identified unmet care needs related to hand function impairment.
View Article and Find Full Text PDFJAMA Netw Open
September 2025
Department of Psychiatry, Psychosomatics, and Psychotherapy, University of Lübeck, Lübeck, Germany.
Importance: Patients with inflammatory rheumatic diseases (IRDs) frequently experience psychological distress; however, access to psychological support remains limited.
Objective: To investigate the effectiveness of a digital psychological intervention for individuals with IRDs.
Design, Setting, And Participants: Participants aged 18 years or older were recruited across Germany between February 22 and June 4, 2024, if they had been diagnosed with rheumatoid arthritis, psoriatic arthritis, or systemic lupus erythematosus and reported psychological distress and reduced quality of life.
Rheumatol Int
September 2025
Clinical Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Kraków, Jakubowskiego 2, Kraków, 30-688, Poland.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by complex disturbances in both innate and adaptive immune responses, often leading to multi-organ involvement. One of the key features of SLE pathogenesis is endothelial dysfunction, which contributes to immune cell infiltration and vascular inflammation. In this context, adhesion molecules such as platelet endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) may reflect the degree of endothelial activation.
View Article and Find Full Text PDFJACC Case Rep
September 2025
Pericardial Disease Program, MedStar Heart and Vascular Institute, Washington, District of Columbia, USA.
Background: Pericardial involvement is common in systemic lupus erythematosus (SLE) and can lead to recurrent episodes. B cell-targeted therapies are commonly used in the treatment of SLE pericarditis. The management of recurrent lupus pericarditis refractory to B cell-targeted therapy remains challenging.
View Article and Find Full Text PDF